Michelle Apperson From UC Davis: Encouraging Clinical Trials for Multiple Sclerosis Patients Helps Greater Good

February 23, 2016
Adam Hochron

Strategic Alliance Partnership | <b>UC Davis Health</b>

As more treatments for multiple sclerosis are developed patients can help not only those affected by the condition now but also those in the future as well by enrolling in properly conducted clinical trials.

As more treatments for multiple sclerosis are developed patients can help not only those affected by the condition now but also those in the future as well by enrolling in properly conducted clinical trials.

Michelle Apperson, MD, PhD, Director of the Multiple Sclerosis Program and an assistant clinical professor at University of California, Davis, discussed the importance of patients engaging in these trials during the annual ACTRIMS meeting in New Orleans. Apperson noted that trials later in development are often the safest for patients and said those listed on the website clinicaltrials.gov follow a strict protocol to ensure patient health and safety through the process.